Suppression of vaccine responses by malaria: insignificant or overlooked? (Q37724859)

22 August 2017

1 reference

title

Suppression of vaccine responses by malaria: insignificant or overlooked? (English)

1 reference

22 August 2017

0 references

0 references

0 references

1 reference

2

Eleanor M Riley

1 reference

22 August 2017

1

Aubrey J Cunnington

1 reference

22 August 2017

1 April 2010

1 reference

Expert Review of Vaccines

22 August 2017

1 reference

22 August 2017

9

1 reference

22 August 2017

409-429

1 reference

22 August 2017

4

1 reference

A malaria control trial using insecticide-treated bed nets and targeted chemoprophylaxis in a rural area of The Gambia, west Africa. 6. The impact of the interventions on mortality and morbidity from malaria

22 August 2017

1 reference

Bacteremia in Malawian children with severe malaria: prevalence, etiology, HIV coinfection, and outcome.

21 January 2018

1 reference

HIV infection, malnutrition, and invasive bacterial infection among children with severe malaria

21 January 2018

1 reference

Severe malaria and concomitant bacteraemia in children admitted to a rural Mozambican hospital.

21 January 2018

1 reference

Exposure to holoendemic malaria results in suppression of Epstein-Barr virus-specific T cell immunosurveillance in Kenyan children

21 January 2018

1 reference

Serological evidence for long-term Epstein-Barr virus reactivation in children living in a holoendemic malaria region of Kenya

21 January 2018

1 reference

Impairment of the immune response to vaccination after acute malaria

21 January 2018

1 reference

The immune response to a meningococcal polysaccharide vaccine in an African village

21 January 2018

1 reference

Immunosuppression in children with malaria

21 January 2018

1 reference

Effect of fever on the serum antibody response of Gambian children to Haemophilus influenzae type b conjugate vaccine.

21 January 2018

1 reference

How many child deaths can we prevent this year?

21 January 2018

1 reference

Key gaps in the knowledge of Plasmodium vivax, a neglected human malaria parasite

21 January 2018

1 reference

Sickle cell trait and the immune response to meningococcal vaccines

21 January 2018

1 reference

Efficacy of atovaquone/proguanil for malaria prophylaxis in children and its effect on the immunogenicity of live oral typhoid and cholera vaccines

21 January 2018

1 reference

Chloroquine treatment of malaria does not increase antibody response to measles vaccination. A controlled study of 580 rural children living in an endemic malaria area

21 January 2018

1 reference

Asymptomatic malaria parasitaemia and the antibody response to tetanus toxoid vaccination.

21 January 2018

1 reference

Randomised study of the possible adjuvant effect of BCG vaccine on the immunogenicity of diphtheria-tetanus-acellular pertussis vaccine in Senegalese infants.

21 January 2018

1 reference

Intermittent treatment for malaria and anaemia control at time of routine vaccinations in Tanzanian infants: a randomised, placebo-controlled trial.

21 January 2018

1 reference

Effect of intermittent treatment with amodiaquine on anaemia and malarial fevers in infants in Tanzania: a randomised placebo-controlled trial

21 January 2018

1 reference

Malaria chemoprophylaxis and the serologic response to measles and diphtheria-tetanus-whole-cell pertussis vaccines

21 January 2018

1 reference

Cellular and humoral responses to tetanus vaccination in Gabonese children

21 January 2018

1 reference

Safety and immunogenicity of RTS,S/AS02D malaria vaccine in infants

21 January 2018

1 reference

Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials.

21 January 2018

1 reference

Do maternally acquired antibodies protect infants from malaria infection?

21 January 2018

1 reference

Can successful vaccines teach us how to induce efficient protective immune responses?

21 January 2018

1 reference

The promise of conjugate vaccines for Africa

21 January 2018

1 reference

Immune responses to polysaccharides: lessons from humans and mice

21 January 2018

1 reference

Efficacy of nine-valent pneumococcal conjugate vaccine against pneumonia and invasive pneumococcal disease in The Gambia: randomised, double-blind, placebo-controlled trial

21 January 2018

1 reference

Effects of measles on the immune response of Nigerian children

21 January 2018

1 reference

Measles vaccination and reduction in child mortality: a community study from Guinea-Bissau

21 January 2018

1 reference

Measles mortality and vaccine efficacy in rural West Africa

21 January 2018

1 reference

Impairment of tetanus-specific cellular and humoral responses following tetanus vaccination in human lymphatic filariasis

21 January 2018

1 reference

The impact of helminths on the response to immunization and on the incidence of infection and disease in childhood in Uganda: design of a randomized, double-blind, placebo-controlled, factorial trial of deworming interventions delivered in pregnancy

21 January 2018

1 reference

Antibody response to measles-mumps-rubella vaccine of children with mild illness at the time of vaccination

21 January 2018

1 reference

Immunogenicity and safety of measles vaccine in ill African children

21 January 2018

1 reference

The development of the RTS,S malaria vaccine candidate: challenges and lessons

21 January 2018

1 reference

NIAID workshop on immunity to malaria: addressing immunological challenges

21 January 2018

1 reference

Transient depletion of T cells with high LFA-1 expression from peripheral circulation during acute Plasmodium falciparum malaria.

21 January 2018

1 reference

Malaria vaccine trials: SPf66 and all that.

21 January 2018

1 reference

Randomised double-blind placebo-controlled trial of SPf66 malaria vaccine in children in northwestern Thailand. Shoklo SPf66 Malaria Vaccine Trial Group

21 January 2018

1 reference

Evaluation of the SPf66 vaccine for malaria control when delivered through the EPI scheme in Tanzania

21 January 2018

1 reference

Randomised trial of efficacy of SPf66 vaccine against Plasmodium falciparum malaria in children in southern Tanzania.

21 January 2018

1 reference

Efficacy trial of malaria vaccine SPf66 in Gambian infants

21 January 2018

1 reference

Efficacy of the RTS,S/AS02A vaccine against Plasmodium falciparum infection and disease in young African children: randomised controlled trial

21 January 2018

1 reference

Safety of the RTS,S/AS02D candidate malaria vaccine in infants living in a highly endemic area of Mozambique: a double blind randomised controlled phase I/IIb trial

21 January 2018

1 reference

Efficacy of RTS,S/AS01E vaccine against malaria in children 5 to 17 months of age

21 January 2018

1 reference

A recombinant blood-stage malaria vaccine reduces Plasmodium falciparum density and exerts selective pressure on parasite populations in a phase 1-2b trial in Papua New Guinea.

21 January 2018

1 reference

Safety and immunogenicity of a three-component blood-stage malaria vaccine (MSP1, MSP2, RESA) against Plasmodium falciparum in Papua New Guinean children

21 January 2018

1 reference

The induction and persistence of T cell IFN-gamma responses after vaccination or natural exposure is suppressed by Plasmodium falciparum

21 January 2018

1 reference

A phase 2b randomised trial of the candidate malaria vaccines FP9 ME-TRAP and MVA ME-TRAP among children in Kenya

21 January 2018

1 reference

Does malaria suffer from lack of memory?

21 January 2018

1 reference

Determination of the processes driving the acquisition of immunity to malaria using a mathematical transmission model

21 January 2018

1 reference

Estimating medium- and long-term trends in malaria transmission by using serological markers of malaria exposure

21 January 2018

1 reference

The effects of varying exposure to malaria transmission on development of antimalarial antibody responses in preschool children. XVI. Asembo Bay Cohort Project

21 January 2018

1 reference

Cellular immune responses to Plasmodium falciparum antigens in children receiving long term anti-malarial chemoprophylaxis

21 January 2018

1 reference

Origins and evolution of antigenic diversity in malaria parasites

21 January 2018

1 reference

Suppression of adaptive immunity to heterologous antigens during Plasmodium infection through hemozoin-induced failure of dendritic cell function

21 January 2018

1 reference

Malaria blood stage suppression of liver stage immunity by dendritic cells

21 January 2018

1 reference

Efficient development of plasmodium liver stage-specific memory CD8+ T cells during the course of blood-stage malarial infection

21 January 2018

1 reference

T cell-independent antigens type 2.

21 January 2018

1 reference

Zwitterionic capsular polysaccharides: the new MHCII-dependent antigens

21 January 2018

1 reference

Human marginal zone B cells.

21 January 2018

1 reference

Marginal zone B cells in lymphocyte activation and regulation

21 January 2018

1 reference

Blood dendritic cells interact with splenic marginal zone B cells to initiate T-independent immune responses.

21 January 2018

1 reference

Migrating monocytes recruited to the spleen play an important role in control of blood stage malaria.

21 January 2018

1 reference

On the function of repetitive domains in protein antigens of Plasmodium and other eukaryotic parasites

21 January 2018

1 reference

Complement activation in Ghanaian children with severe Plasmodium falciparum malaria

21 January 2018

1 reference

Complement consumption in children with Plasmodium falciparum malaria

21 January 2018

1 reference

Fatal Plasmodium falciparum malaria causes specific patterns of splenic architectural disorganization

21 January 2018

1 reference

Intermittent preventive treatment of malaria in infants: how does it work and where will it work?

21 January 2018

1 reference

Global immunization: status, progress, challenges and future

21 January 2018

1 reference

Immune responses to Plasmodium vivax pre-erythrocytic stage antigens in naturally exposed Duffy-negative humans: a potential model for identification of liver-stage antigens

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1586/ERV.10.16

1 reference

22 August 2017

1 reference

PubMed ID

20370551